AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2020
Jan 8, 2020
35021_dirs_2020-01-08_25a705ee-e9a2-46e1-a4c2-567735853ac0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-01-06
Reporting Person: Grachev Igor D (Chief Medical Officer)
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4
Annual Report
2026
Mar 4
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 4